Showing results (1-10 of 951) with videos related to
Sort By:
Pageof 96
Current Opinion in Nephrology and Hypertension|July 27, 2022
Treatment potential in APOL1-associated nephropathyDavid J Friedman, Lijun Ma, Barry I FreedmanKidney Research and Clinical Practice|June 16, 2026
Kidney disease in patients with two APOL1 risk variantsBarry I Freedman, Lijun MaThe Review of Diabetic Studies : RDS|September 14, 2012
Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complicationsMariana Murea, Lijun Ma, Barry I FreedmanTransplantation|October 30, 2018
Mechanisms of Injury in APOL1-associated Kidney DiseaseLijun Ma, Jasmin Divers, Barry I FreedmanCurrent Opinion in Nephrology and Hypertension|May 2, 2025
APOL1 testing in clinical practice and opportunities for new therapiesTaewoo Lee, Lijun Ma, Barry I FreedmanAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 23, 2018
APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKDBarry I Freedman, Sophie Limou, Lijun Ma, et al.Current Opinion in Nephrology and Hypertension|October 16, 2018
Protective association between JC polyoma viruria and kidney diseaseJasmin Divers, Carl D Langefeld, Douglas S Lyles, et al.Kidney360|October 6, 2025
Serum AKR1A1 Levels Predict eGFR Decline Rate in African Americans with Type 2 DiabetesLijun Ma, Young A Choi, DengFeng Li, et al.Clinical Journal of the American Society of Nephrology : CJASN|November 6, 2010
Lipotoxicity in diabetic nephropathy: the potential role of fatty acid oxidationMariana Murea, Barry I Freedman, John S Parks, et al.Pageof 96